맞춤형 암백신 시장 보고서(2026년)

Personalized cancer vaccines are treatments customized to a patient's distinct tumor characteristics, designed to activate their immune system against cancer cells. They enhance the body's capacity to identify and combat particular cancer types, which may boost treatment effectiveness and lower the risk of relapse.

The primary categories of personalized cancer vaccines consist of preventive and therapeutic types. Preventive cancer vaccines aim to safeguard against infections or conditions that could potentially cause cancer. They target multiple cancer types, such as lung cancer, breast cancer, colorectal cancer, leukemia, prostate cancer, cervical cancer, and glioblastoma, via diverse mechanisms including tumor-associated antigens (TAAs), tumor-specific antigens (TSAs), somatic mutations in cancer pharmacogenomics, pharmacogenomics related to genomic polymorphisms, and additional approaches. Delivery occurs through various administration routes, like injectables and others, across different settings including hospitals, clinics, and more.

Tariffs have increased costs for imported sequencing tools, bioinformatics hardware, reagents, and biologic components used in personalized cancer vaccine development. These impacts are most evident in advanced markets where precision oncology programs depend on highly specialized global suppliers. Rising tariff related expenses have added pressure to research budgets and early stage manufacturing costs. This has influenced commercialization timelines and partnership strategies for personalized vaccine platforms. However, tariffs are also encouraging domestic innovation, local technology development, and localized manufacturing capabilities for next generation cancer vaccines over the long term.

The personalized cancer vaccines market research report is one of a series of new reports from The Business Research Company that provides personalized cancer vaccines market statistics, including personalized cancer vaccines industry global market size, regional shares, competitors with a personalized cancer vaccines market share, detailed personalized cancer vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer vaccines industry. This personalized cancer vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized cancer vaccines market size has grown strongly in recent years. It will grow from $256.65 billion in 2025 to $273.05 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to advances in cancer genomics, unmet need in oncology treatments, limitations of traditional cancer therapies, growth in immunotherapy research, increased funding for cancer research.

The personalized cancer vaccines market size is expected to see strong growth in the next few years. It will grow to $350.3 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to expansion of personalized medicine adoption, increasing cancer incidence rates, progress in neoantigen discovery, rising collaboration between biotech firms, supportive regulatory frameworks. Major trends in the forecast period include rising focus on personalized immunotherapy, increasing use of genomic tumor profiling, expansion of therapeutic cancer vaccines, growing integration with precision oncology, higher clinical trial activity in cancer vaccines.

The rising incidence of cancer is anticipated to fuel expansion in the personalized cancer vaccine market. Cancer encompasses a range of diseases marked by uncontrolled cell proliferation that can infiltrate nearby tissues and metastasize to distant body sites. This surge in cancer cases stems from aging demographics, shifts in lifestyle, environmental factors, and advances in detection methods. Personalized cancer vaccines aid oncology treatment by providing customized formulations based on individual tumor antigens, enhancing the immune system's capacity to detect and destroy malignant cells. For instance, in July 2024, the Australian Institute of Health and Welfare (AIHW), an Australia-based government body, reported that cancer diagnoses in Australia climbed from 160,570 in 2022 to 164,694 in 2023, reflecting a notable annual uptick. Thus, the growing burden of cancer is propelling the personalized cancer vaccine market forward.

Major companies in the personalized cancer vaccine market are prioritizing the development of cutting-edge therapeutic options, like personalized immunotherapy tailored to individual patient tumor mutations, to boost treatment accuracy and patient outcomes. Personalized immunotherapy involves bespoke cancer therapies that leverage a patient's unique genetic and tumor mutation data, often administered via dendritic cell vaccines or neoantigen-specific platforms, to trigger a customized immune attack on cancer cells. For example, in August 2024, UCLA Health, a US-based healthcare provider, initiated a pioneering clinical trial for a personalized cancer vaccine targeting the H3 G34 mutation in diffuse hemispheric gliomas; it employs dendritic cells to provoke an immune response against the RNA alterations from this aggressive mutation, providing a hopeful new avenue for adolescents and young adults facing scarce options and low survival rates.

In June 2025, BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V. for an undisclosed amount. Through this acquisition, BioNTech seeks to bolster its research, development, manufacturing, and commercialization efforts in mRNA-based cancer immunotherapy, while advancing its oncology strategy. CureVac N.V., a Germany-based company, specializes in developing personalized cancer vaccines.

Major companies operating in the personalized cancer vaccines market are Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized cancer vaccines market consists of sales of patient-specific vaccines, neoantigen-based therapies, dendritic cell-based vaccines and peptide-based immunotherapies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Cancer Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses personalized cancer vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized cancer vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized cancer vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines
• 2) By Cancer Type: Lung Cancer; Breast Cancer; Colorectal Cancer; Leukemia; Prostate Cancer; Cervical Cancer; Glioblastoma
• 3) By Mechanism Of Action: Tumor Associated Antigens (TAAs); Tumor Specific Antigens (TSAs); Somatic Mutations In Cancer Pharmacogenomics; Pharmacogenomics Towards Genomic Polymorphism; Other Mechanisms Of Action
• 4) By Route Of Administration: Injectables; Other Routes Of Administration
• 5) By End Use: Hospitals; Clinic; Other End Users
• Subsegments:
• 1) By Preventive Cancer Vaccines: HPV Vaccines; Hepatitis B Vaccines; Combination Vaccines
• 2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines; Peptide-Based Vaccines; DNA Vaccines; RNA Vaccines; Whole Cell Vaccines
• Companies Mentioned: Moderna Inc.; CureVac AG; BioNTech SE; Genentech Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Achilles Therapeutics Plc; Evaxion Biotech AS; Geneos Therapeutics Inc.; ISA Pharmaceuticals BV; VAXIMM GmbH; EpiVax Therapeutics Inc.; Personalis Inc.; Catalent Inc.; Gritstone bio Inc.; Neon Therapeutics Inc.; Nouscom AG; Vaccitech plc; Agenus Inc.; Transgene SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Personalized Cancer Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Personalized Cancer Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Personalized Cancer Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Personalized Cancer Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Focus On Personalized Immunotherapy
  • 4.2.2 Increasing Use Of Genomic Tumor Profiling
  • 4.2.3 Expansion Of Therapeutic Cancer Vaccines
  • 4.2.4 Growing Integration With Precision Oncology
  • 4.2.5 Higher Clinical Trial Activity In Cancer Vaccines

5. Personalized Cancer Vaccines Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Cancer Treatment Centers
• 5.3 Oncology Clinics
• 5.4 Research Institutes
• 5.5 Biotechnology Companies

6. Personalized Cancer Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Personalized Cancer Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Personalized Cancer Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Personalized Cancer Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Personalized Cancer Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Personalized Cancer Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Personalized Cancer Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Personalized Cancer Vaccines Market Segmentation

• 9.1. Global Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
• 9.2. Global Personalized Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma
• 9.3. Global Personalized Cancer Vaccines Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action
• 9.4. Global Personalized Cancer Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injectables, Other Routes Of Administration
• 9.5. Global Personalized Cancer Vaccines Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinic, Other End Users
• 9.6. Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Preventive Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines
• 9.7. Global Personalized Cancer Vaccines Market, Sub-Segmentation Of Therapeutic Cancer Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

10. Personalized Cancer Vaccines Market Regional And Country Analysis

• 10.1. Global Personalized Cancer Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Personalized Cancer Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Personalized Cancer Vaccines Market

• 11.1. Asia-Pacific Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Personalized Cancer Vaccines Market

• 12.1. China Personalized Cancer Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Personalized Cancer Vaccines Market

• 13.1. India Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Personalized Cancer Vaccines Market

• 14.1. Japan Personalized Cancer Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Personalized Cancer Vaccines Market

• 15.1. Australia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Personalized Cancer Vaccines Market

• 16.1. Indonesia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Personalized Cancer Vaccines Market

• 17.1. South Korea Personalized Cancer Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Personalized Cancer Vaccines Market

• 18.1. Taiwan Personalized Cancer Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Personalized Cancer Vaccines Market

• 19.1. South East Asia Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Personalized Cancer Vaccines Market

• 20.1. Western Europe Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Personalized Cancer Vaccines Market

• 21.1. UK Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Personalized Cancer Vaccines Market

• 22.1. Germany Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Personalized Cancer Vaccines Market

• 23.1. France Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Personalized Cancer Vaccines Market

• 24.1. Italy Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Personalized Cancer Vaccines Market

• 25.1. Spain Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Personalized Cancer Vaccines Market

• 26.1. Eastern Europe Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Personalized Cancer Vaccines Market

• 27.1. Russia Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Personalized Cancer Vaccines Market

• 28.1. North America Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Personalized Cancer Vaccines Market

• 29.1. USA Personalized Cancer Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Personalized Cancer Vaccines Market

• 30.1. Canada Personalized Cancer Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Personalized Cancer Vaccines Market

• 31.1. South America Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Personalized Cancer Vaccines Market

• 32.1. Brazil Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Personalized Cancer Vaccines Market

• 33.1. Middle East Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Personalized Cancer Vaccines Market

• 34.1. Africa Personalized Cancer Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Personalized Cancer Vaccines Market, Segmentation By Treatment Type, Segmentation By Cancer Type, Segmentation By Mechanism Of Action, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Personalized Cancer Vaccines Market Regulatory and Investment Landscape

36. Personalized Cancer Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Personalized Cancer Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Personalized Cancer Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Personalized Cancer Vaccines Market Company Profiles
  • 36.3.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. CureVac AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Personalized Cancer Vaccines Market Other Major And Innovative Companies

• GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

38. Global Personalized Cancer Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Personalized Cancer Vaccines Market

40. Personalized Cancer Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Personalized Cancer Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Personalized Cancer Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Personalized Cancer Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer